Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Feb 26;30(Suppl 1):I-16–I-24. doi: 10.1002/clc.20049

Trials and tribulations associated with angina and traditional therapeutic approaches

Prakash C Deedwania 1,✉, Enrique V Carbajal 1, Vishnu R Bobba 1
PMCID: PMC6653403  PMID: 18373326

Abstract

Ischemic heart disease is the foremost cause of death in the United States and the developed countries. Stable angina is the initial manifestation of ischemic heart disease in one half of the patients and becomes a recurrent symptom in survivors of myocardial infarction (MI) and other forms of acute coronary syndromes (ACS). There are multiple therapeutic modalities currently available for treatment of anginal symptoms in patients with stable CAD. These include anti‐anginal drugs and myocardial revascularization procedures such as coronary artery bypass graft surgery (CABGS), percutaneous transluminal coronary angioplasty (PTCA) and percutaneous coronary intervention (PCI). Anti‐anginal drug therapy is based on treatment with nitrates, beta blockers, and calcium channel blockers. A newly approved antianginal drug, ranolazine, is undergoing phase III evaluation. Not infrequently, combination therapy is often necessary for adequate symptom control in some patients with stable angina. Howerever, there has not been a systematic evaluation of individual or combination antianginal grug therapy on hard clinical end points in patients with stable angina. Most revascularization trials that have evaluated treatment with CABGS, PTCA, or PCI in patients with chronic CAD and stable angina have not shown significant improvement in survival or decreased incidence of non‐fatal MI compared to medical treatment. In the CABGS trials, various post‐hoc analyses have identified several smaller subgroups at high‐risk in whom CABGS might improve clinical outcomes. However, there are conflicting findings in different reports and these findings are futher compromised due to the heterogeneous groups of patients in these trials. Moreover, no prospective randomized controlled trial (RCT) has confirmed an advantage of CABGS, compared to medical treatment, in reduction of hard clinical outcomes in any of the high‐risk subgroups. Based on the available data, it appears reasonable to conclude that for most patients (except perhaps in those with presence of left main disease > 50% stenosis) there is no apparent survival benefit of CABGS compared to medical therapy in stable CAD patients with angina. Although these trial have reported better symptom control associated with the revascularization intervention in most patients, this has not been adequately compared using modern medical therapies. Available data from recent studies also suggest treatment with an angiotensin converting enzyme inhibitor (ACEI), a statin and a regular exercise regimen in patients with stable CAD and angina pectoris. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: ACE, ACIP, ACME, ACTION, AVERT, beta‐blockers, CASS, ECSS, MASS, MERLIN, nitrates, perindopril, PTCA, RCT, RITA‐2, SAGE, SCRIP, TIME, VACSS

Full Text

The Full Text of this article is available as a PDF (270.2 KB).

REFERENCES

  • 1. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, et al.: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002. [DOI] [PubMed]
  • 2. Fox K, Garcia MA, Ardissino D, Morais J, Zamorano JL, et al.: Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27(11): 1341–1381. [DOI] [PubMed] [Google Scholar]
  • 3. Holubkov R, Laskey WK, Haviland A, Slater JC, Bourassa MG, et al.: NHLBI Dynamic Registry. Registry Investigators. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. Am Heart J 2002; 144: 826–833. [DOI] [PubMed] [Google Scholar]
  • 4. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, et al.: History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003; 145: 493–499. [DOI] [PubMed] [Google Scholar]
  • 5. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med 2005; 352(24): 2524–2533. [DOI] [PubMed] [Google Scholar]
  • 6. Abrams J, Thadani U. Therapy of stable angina pectoris: the uncomplicated patient. Circulation 2005; 112: e255–e259. [DOI] [PubMed] [Google Scholar]
  • 7. Opie LH, Commerford PJ, Gersh BJ. Controversies in stable coronary artery disease. Lancet 2006; 367: 69–78. [DOI] [PubMed] [Google Scholar]
  • 8. Reiter MJ. Cardiovascular drug class specificity: beta‐blockers. Prog Cardiovasc Dis 2004; 47(1): 11–33. [DOI] [PubMed] [Google Scholar]
  • 9. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, et al.: The Atenolol Silent Ischemia Study (ASIST). Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. Circulation 1994; 90: 762–768. [DOI] [PubMed] [Google Scholar]
  • 10. Poole‐Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, et al.: A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Effect of long‐acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial. Lancet 2004; 364: 849–857. [DOI] [PubMed] [Google Scholar]
  • 11. Takaro T, Hultgren HN, Detre KM, participants in the VA cooperative study. VA cooperative study of coronary arterial surgery. II. Left main disease. Circulation 1975; 52(Suppl 2): 143. [PubMed] [Google Scholar]
  • 12. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 1976; 54(Suppl 6): III107–III117. [PubMed] [Google Scholar]
  • 13. Detre K, The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven‐year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333–1339. [DOI] [PubMed] [Google Scholar]
  • 14. Peduzzi P, Kamina A, Detre K, The VA coronary artery bypass surgery cooperative study group. Twenty‐two‐year follow‐up in the VA cooperative study of coronary artery bypass surgery for stable angina. Am J Cardiol 1998; 81: 1393–1399. [DOI] [PubMed] [Google Scholar]
  • 15. Takaro T, Peduzzi P, Detre KM, Hultgren HN, Murphy ML, et al.: Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 1982; 66: 14–22. [DOI] [PubMed] [Google Scholar]
  • 16. Murphy M, Hultgren H, Detre K, Thomsen J, Takaro T, Participants of the Veterans Administration cooperative study. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med 1977; 297: 621–627. [DOI] [PubMed] [Google Scholar]
  • 17.The VA coronary artery bypass surgery cooperative study group. 18‐year follow up in the Veterans Affairs cooperative study of coronary bypass surgery for stable angina. Circulation 1992; 86: 121–130. [DOI] [PubMed] [Google Scholar]
  • 18.European Coronary Surgery Study Group. Coronary artery bypass surgery in stable angina pectoris: survival at two years. Lancet 1979; 1: 889–893. [PubMed] [Google Scholar]
  • 19. Varnauskas E. Twelve‐year follow‐up of survival in the randomized European coronary surgery study. N Engl J Med 1988; 319: 332–337. [DOI] [PubMed] [Google Scholar]
  • 20.Second interim report by the European coronary surgery Study Group. Prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1980; 2: 491–495. [PubMed] [Google Scholar]
  • 21.European coronary surgery study group. Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: a progress report on survival. Circulation 1982; 65: 67–71. [DOI] [PubMed] [Google Scholar]
  • 22.European Coronary Surgery Study Group. Long‐term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173–1180. [PubMed] [Google Scholar]
  • 23. Varnauskas E. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery. Circulation 1985; 72(6 Pt 2): V90–101. [PubMed] [Google Scholar]
  • 24.The principal investigators of CASS and their associates. The national heart, lung and blood institute coronary artery surgery study (CASS) Circulation 1981; 63(Suppl I): I–1. [Google Scholar]
  • 25. Fisher L. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med 1984; 310: 750–758. [DOI] [PubMed] [Google Scholar]
  • 26. Killip T, Passamani E, Davis K. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow‐up and survival in patients with reduced ejection fraction. Circulation 1985; 72(6 Pt 2): V102–V109. [PubMed] [Google Scholar]
  • 27. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, et al.: Ten‐year follow‐up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 1990; 82: 1629–1646. [DOI] [PubMed] [Google Scholar]
  • 28. Fisher L. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983; 68: 939–950. [DOI] [PubMed] [Google Scholar]
  • 29. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, et al.: The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995; 26(7): 1600–1605. [DOI] [PubMed] [Google Scholar]
  • 30. Hueb WA, Soares PR, Almeida De Oliveira S, Arie S, Cardoso RH et al.: Five‐year follow‐op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 1999; 100(Suppl 19): II107–II113. [DOI] [PubMed] [Google Scholar]
  • 31.The ACIP investigators. Asymptomatic cardiac ischemia pilot study (ACIP). Am J Cardiol 1992; 70: 744. [DOI] [PubMed] [Google Scholar]
  • 32. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, et al.: The ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 1995; 26: 594–605. [DOI] [PubMed] [Google Scholar]
  • 33. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, et al.: The medicine, angioplasty, or surgery study (MASS‐II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one‐year results. J Am Coll Cardiol 2004; 43(10): 1743–1751. [DOI] [PubMed] [Google Scholar]
  • 34. Spargias KS, Cokkinos DV. Medical versus interventional management of stable angina. Coron Artery Dis 2004; 15(Suppl 1): S5–S10. [DOI] [PubMed] [Google Scholar]
  • 35. Parisi AF, Folland ED, Hartigan P, Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single‐vessel coronary artery disease. N Engl J Med 1992; 326(1): 10–16. [DOI] [PubMed] [Google Scholar]
  • 36.The TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary‐artery disease (TIME): a randomized trial. Lancet 2001; 358: 951–957. [DOI] [PubMed] [Google Scholar]
  • 37. Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, et al.: Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy. One year results of the randomized TIME trial. JAMA 2003; 289: 1117–1123. [DOI] [PubMed] [Google Scholar]
  • 38. Pocock S. RITA‐2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomized Intervention Treatment of Angina (RITA‐2) trial. Lancet 1997; 350: 461–68. [PubMed] [Google Scholar]
  • 39. Henderson R, Pocock S, Clayton T, Knight R, Fox K, et al.: The Second Randomized Intervention Treatment of Angina (RITA‐2). Trial Participants Seven‐Year Outcome in the RITA‐2 Trial: Coronary Angioplasty versus Medical Therapy. J Am Coll Cardiol 2003; 42: 1161–1170. [DOI] [PubMed] [Google Scholar]
  • 40. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta‐analysis. Circulation 2005; 111: 2906–2912. [DOI] [PubMed] [Google Scholar]
  • 41.The heart outcomes prevention evaluation study investigators. Effects of an angiotension‐converting‐enzyme inhibitor, Ramipril on cardiovascular events in high‐risk patients. N Engl J Med 2000; 342: 145–153. [DOI] [PubMed] [Google Scholar]
  • 42.The European trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double‐blind, placebo‐controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782–88. [DOI] [PubMed] [Google Scholar]
  • 43. Al‐Mallah MH, Tleyjeh IM, Abdel‐Latif AA, Weaver WD. Angiotensin‐converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta‐analysis of randomized controlled trials. J Am Coll Cardiol 2006; 47: 1576–1583. [DOI] [PubMed] [Google Scholar]
  • 44.Scandinavian Simvastatin Survival Study group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389. [PubMed] [Google Scholar]
  • 45. Schwartz G, Olsson A, Ezekowitz M, Ganz P, Oliver M, et al.: the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial JAMA 2001; 285: 1711–1718. [DOI] [PubMed] [Google Scholar]
  • 46. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, et al.: Atorvastatin versus Revascularization Treatment Investigators. Aggressive lipid‐lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999; 341: 70–76. [DOI] [PubMed] [Google Scholar]
  • 47. Stone PH, Lloyd‐Jones DM, Kinlay S, Frei B, Carlson W, et al.: Vascular Basis Study Group. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation 2005; 111: 1747–1755. [DOI] [PubMed] [Google Scholar]
  • 48. Deedwania PC, Study Assessing Goals in the Elderly steering committee and investigators. Effect of aggressive versus moderate lipid‐lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). Am Heart J 2004; 148: 1053–1059. [DOI] [PubMed] [Google Scholar]
  • 49. Hambrecht R, Walther C, Mobius‐Winkler S, Gielen S, Linke A, et al.: Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004; 109(11): 1371–1378. [DOI] [PubMed] [Google Scholar]
  • 50. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, et al.: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89(3): 975–990. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES